A higher peak in GRP78 expression was observed in the T2D vs. control group (Figure 2A; p < 0.05); similarly, DDIT3/CHOP expression was augmented in T2D patients (Figure 2B; p < 0.05). This evidence concerns the gene DDIT3 and type 2 diabetes mellitus.